+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation



Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation



Journal of Gastroenterology & Hepatology 16(2): 190-195



Background and Aims: Hepatic steatosis is a histological characteristic in patients with chronic hepatitis C virus (HCV) infection. The aim of this study was to evaluate the prevalence of hepatic steatosis in Chinese patients with chronic hepatitis C, and to look for possible correlation with various histopathological changes and to look for possible correlation with various clinical and pathologic variables. Methods: One hundred and six patients were enrolled, and patients with alcoholism or diabetes mellitus were excluded. Clinical, biochemical and virologic data, including HCV genotype and serum HCV-RNA titer and histological findings, were compared between patients with and without hepatic steatosis. Results: Fifty-five (52%) of the 106 patients with chronic hepatitis C had hepatic steatosis. Patients with hepatic steatosis had significantly higher mean serum levels of triglyceride and gamma-glutamyl transpeptidase, higher body mass index, and a higher incidence of obesity compared with patients without hepatic steatosis. No significant differences in serum HCV-RNA titer and HCV genotype or the response to interferon therapy were noted between the two groups. Histological analysis showed patients with hepatic steatosis had a significantly higher mean fibrotic score than patients without hepatic steatosis (1.9 +- 1.2 vs 1.3 +- 1.0; P=0.016). There were no significant differences in the severity of necroinflammation, the presence of lymphoid aggregation/follicle or bile duct damage between the two groups. Multivariate logistic regression analysis showed that independent predictors associated with hepatic steatosis were obesity or a histology fibrotic score of gtoreq2. Conclusion: It was found that 52% of Chinese patients with chronic hepatitis C had hepatic steatosis. Patients with hepatic steatosis were more frequently obese and had more severe hepatic fibrosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010743210

Download citation: RISBibTeXText

PMID: 11207900

DOI: 10.1046/j.1440-1746.2001.02407.x


Related references

Hepatitis C virus infection: clinical, virologic and pathologic features: hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. Journal of Gastroenterology and Hepatology 16(2): 190-195, 2001

Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. Journal of Hepatology 44(6): 1026-1032, 2006

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection. Advances in Therapy 24(5): 972-982, 2007

Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pacific Journal of Cancer Prevention 15(9): 3879-3884, 2014

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. Journal of Gastroenterology and Hepatology 23(5): 779-782, 2008

Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver International 27(6): 748-757, 2007

Hepatic Steatosis and its Effects on Fibrosis in Patients With Chronic Hepatitis B Virus Infection. Clinical Gastroenterology and Hepatology 16(4): 491-494, 2018

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. Journal of Gastroenterology and Hepatology 23(9): 1419-1425, 2008

Detection of a common deletion in the mitochondrial DNA of patients with chronic hepatitis C virus infection and hepatic steatosis. Hepatology 32(4 Pt 2): 226A, 2000

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97(12): 3036-3043, 2003

Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma?. Cancer 97(12): 2948-2950, 2003

The Role of Promyelocytic Leukemia Protein in Steatosis-Associated Hepatic Tumors Related to Chronic Hepatitis B virus Infection. Translational Oncology 11(3): 743-754, 2018

Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection. European Journal of Clinical Microbiology and Infectious Diseases 33(10): 1725-1732, 2014

Prevalence and clinical associations of previous and occult hepatitis B virus infection in hepatitis C virus positive and hepatitis B virus surface antigen negative patients with chronic liver disease. Hepatology 34(4 Pt 2): 562A, 2001

TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group. Journal of Hepatology 32(2): 339-343, 2000